Phase II Study Evaluating Ivosidenib Maintenance After SOC Adjuvant Chemotherapy in Curative mIDH1 Cholangiocarcinoma
Status:
RECRUITING
Trial end date:
2031-12-01
Target enrollment:
Participant gender:
Summary
This study trial is a prospective, multicentre, exploratory, single-arm, open-label phase II study to evaluat ivosidenib maintenance after SOC adjuvant chemotherapy in curative mIDH1 cholangiocarcinoma
Phase:
PHASE2
Details
Lead Sponsor:
Institut fr Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Collaborators:
Servier Affaires Mdicales Servier Deutschland GmbH